Yuanlin Xu

953 total citations · 1 hit paper
33 papers, 715 citations indexed

About

Yuanlin Xu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Yuanlin Xu has authored 33 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 8 papers in Physiology. Recurrent topics in Yuanlin Xu's work include Erythrocyte Function and Pathophysiology (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and MicroRNA in disease regulation (3 papers). Yuanlin Xu is often cited by papers focused on Erythrocyte Function and Pathophysiology (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and MicroRNA in disease regulation (3 papers). Yuanlin Xu collaborates with scholars based in China, United States and Canada. Yuanlin Xu's co-authors include Shujun Yang, Shiyong Zhou, Huilai Zhang, Xihong Zhang, Xiufeng Hu, Peipei Zhang, Yanyan Liu, Shijie Zhang, Xiuli An and Huizhi Zhao and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yuanlin Xu

29 papers receiving 707 citations

Hit Papers

Carbon Dots as a Potentia... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanlin Xu China 12 324 162 141 135 105 33 715
Yue Yin China 14 333 1.0× 156 1.0× 79 0.6× 56 0.4× 70 0.7× 74 773
Paz de la Torre Spain 17 302 0.9× 89 0.5× 49 0.3× 144 1.1× 91 0.9× 31 816
Agnieszka Zimna Poland 9 341 1.1× 186 1.1× 33 0.2× 100 0.7× 65 0.6× 24 709
Jang‐Seong Kim South Korea 14 337 1.0× 179 1.1× 43 0.3× 69 0.5× 92 0.9× 27 662
Jonathan S. Rink United States 13 249 0.8× 184 1.1× 68 0.5× 157 1.2× 79 0.8× 29 617
Michelle Santoso United States 11 531 1.6× 193 1.2× 84 0.6× 147 1.1× 35 0.3× 15 836
Shisheng Li China 18 466 1.4× 270 1.7× 42 0.3× 196 1.5× 96 0.9× 68 974
Jianfeng Zhou China 16 278 0.9× 185 1.1× 32 0.2× 84 0.6× 75 0.7× 55 716

Countries citing papers authored by Yuanlin Xu

Since Specialization
Citations

This map shows the geographic impact of Yuanlin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanlin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanlin Xu more than expected).

Fields of papers citing papers by Yuanlin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanlin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanlin Xu. The network helps show where Yuanlin Xu may publish in the future.

Co-authorship network of co-authors of Yuanlin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanlin Xu. A scholar is included among the top collaborators of Yuanlin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanlin Xu. Yuanlin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yuanlin, et al.. (2025). Megabase-scale loss of heterozygosity provoked by CRISPR-Cas9 DNA double-strand breaks. Molecular Cell. 85(22). 4119–4137.e10. 1 indexed citations
2.
Li, Zhiyong, Yuanlin Xu, Huan Zhang, et al.. (2024). PLK1 inhibition impairs erythroid differentiation. Frontiers in Cell and Developmental Biology. 12. 1516704–1516704. 1 indexed citations
3.
Li, Weilong, Ming Xu, Jie Gu, et al.. (2024). Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia. BMC Musculoskeletal Disorders. 25(1). 937–937. 2 indexed citations
4.
Xu, Yuanlin, Yating Li, Huan Zhang, et al.. (2024). A novel role of AURKA kinase in erythroblast enucleation. Haematologica. 109(11). 3721–3734. 1 indexed citations
5.
Xu, Yuanlin, et al.. (2024). DNA nicks in both leading and lagging strand templates can trigger break-induced replication. Molecular Cell. 85(1). 91–106.e5. 8 indexed citations
6.
Zhang, Shijie, Yuanlin Xu, Chao Jiang, et al.. (2023). Intracerebral Hemorrhage Leads to Anemia By Disrupting Erythropoiesis and Erythromyeloblastic Islands. Blood. 142(Supplement 1). 3821–3821.
7.
Zheng, Tingting, Panpan Chen, Yuanlin Xu, et al.. (2023). Comprehensive analysis of thirteen-gene panel with prognosis value in Multiple Myeloma. Cancer Biomarkers. 38(4). 583–593.
8.
Zhao, Peiqi, Yuanlin Xu, Wei Ji, et al.. (2022). Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy. SHILAP Revista de lepidopterología. 29 indexed citations
9.
Chen, Panpan, Yuanlin Xu, Yan Li, et al.. (2022). Novel gene signature reveals prognostic model in acute lymphoblastic leukemia. Frontiers in Cell and Developmental Biology. 10. 1036312–1036312. 4 indexed citations
10.
Xu, Yuanlin, Boyang Wang, Jingxin Zhang, et al.. (2022). Carbon Dots as a Potential Therapeutic Agent for the Treatment of Cancer‐Related Anemia. Advanced Materials. 34(19). e2200905–e2200905. 126 indexed citations breakdown →
11.
Gu, Jie, et al.. (2021). lncRNA HCG11 suppresses human osteosarcoma growth through upregulating p27 Kip1. Aging. 13(17). 21743–21757. 12 indexed citations
12.
Yan, Zheng, Wenping Zhou, Zhihua Yao, et al.. (2020). A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progression. Biomarker Research. 8(1). 33–33. 11 indexed citations
13.
Li, Wei, Yaomei Wang, Huizhi Zhao, et al.. (2019). Identification and transcriptome analysis of erythroblastic island macrophages. Blood. 134(5). 480–491. 111 indexed citations
14.
Yao, Zhihua, Yuan Tian, Haiying Wang, et al.. (2017). MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma. Tumor Biology. 39(6). 3726131641–3726131641. 52 indexed citations
15.
Chen, Ling, Yi Liu, Yuanlin Xu, et al.. (2017). Improving the cytological diagnosis of high‐grade serous carcinoma in ascites with a panel of complementary biomarkers in cell blocks. Cytopathology. 29(3). 247–253. 3 indexed citations
16.
Xu, Yuanlin, et al.. (2017). Parosteal ossifying lipoma of the clavicle: A case report. Molecular and Clinical Oncology. 6(3). 419–421. 3 indexed citations
17.
Yao, Shuna, Junbo Li, Zhihua Yao, et al.. (2017). Extranodal involvement in young patients with diffuse large B-cell lymphoma: distribution, prognostic value and treatment options. Chinese Journal of Cancer Research. 29(1). 57–65. 11 indexed citations
18.
Guo, Jian, et al.. (2015). N-acetylcysteine treatment following spinal cord trauma reduces neural tissue damage and improves locomotor function in mice. Molecular Medicine Reports. 12(1). 37–44. 20 indexed citations
19.
Guo, Jian, Bin Zhang, Yuanlin Xu, et al.. (2014). Targeting endothelin receptors A and B attenuates the inflammatory response and improves locomotor function following spinal cord injury in mice. International Journal of Molecular Medicine. 34(1). 74–82. 19 indexed citations
20.
Qin, Wei, et al.. (2005). Isolation, characterisation and antifungal activity of β-1,3-glucanase from seeds of Jatropha curcas. South African Journal of Botany. 71(1). 95–99. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026